Literature DB >> 28137908

The PP2A-B56 Phosphatase Opposes Cyclin E Autocatalytic Degradation via Site-Specific Dephosphorylation.

Ryan J Davis1,2, Jherek Swanger1, Bridget T Hughes1, Bruce E Clurman3.   

Abstract

Cyclin E, in conjunction with its catalytic partner cyclin-dependent kinase 2 (CDK2), regulates cell cycle progression as cells exit quiescence and enter S-phase. Multiple mechanisms control cyclin E periodicity during the cell cycle, including phosphorylation-dependent cyclin E ubiquitylation by the SCFFbw7 ubiquitin ligase. Serine 384 (S384) is the critical cyclin E phosphorylation site that stimulates Fbw7 binding and cyclin E ubiquitylation and degradation. Because S384 is autophosphorylated by bound CDK2, this presents a paradox as to how cyclin E can evade autocatalytically induced degradation in order to phosphorylate its other substrates. We found that S384 phosphorylation is dynamically regulated in cells and that cyclin E is specifically dephosphorylated at S384 by the PP2A-B56 phosphatase, thereby uncoupling cyclin E degradation from cyclin E-CDK2 activity. Furthermore, the rate of S384 dephosphorylation is high in interphase but low in mitosis. This provides a mechanism whereby interphase cells can oppose autocatalytic cyclin E degradation and maintain cyclin E-CDK2 activity while also enabling cyclin E destruction in mitosis, when inappropriate cyclin E expression is genotoxic.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  cell cycle; cyclin-dependent kinases; cyclins; serine/threonine phosphatases; ubiquitination

Mesh:

Substances:

Year:  2017        PMID: 28137908      PMCID: PMC5376636          DOI: 10.1128/MCB.00657-16

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.

Authors:  Elizabeth Yeh; Melissa Cunningham; Hugh Arnold; Dawn Chasse; Teresa Monteith; Giovanni Ivaldi; William C Hahn; P Todd Stukenberg; Shirish Shenolikar; Takafumi Uchida; Christopher M Counter; Joseph R Nevins; Anthony R Means; Rosalie Sears
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

Review 2.  Phosphatases: providing safe passage through mitotic exit.

Authors:  Claudia Wurzenberger; Daniel W Gerlich
Journal:  Nat Rev Mol Cell Biol       Date:  2011-07-13       Impact factor: 94.444

3.  p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation.

Authors:  Alex C Minella; Jherek Swanger; Eileen Bryant; Markus Welcker; Harry Hwang; Bruce E Clurman
Journal:  Curr Biol       Date:  2002-10-29       Impact factor: 10.834

4.  Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.

Authors:  G A Calin; M G di Iasio; E Caprini; I Vorechovsky; P G Natali; G Sozzi; C M Croce; G Barbanti-Brodano; G Russo; M Negrini
Journal:  Oncogene       Date:  2000-02-24       Impact factor: 9.867

5.  A mouse model for cyclin E-dependent genetic instability and tumorigenesis.

Authors:  Keith R Loeb; Heather Kostner; Eduardo Firpo; Thomas Norwood; Karen D Tsuchiya; Bruce E Clurman; James M Roberts
Journal:  Cancer Cell       Date:  2005-07       Impact factor: 31.743

6.  Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation.

Authors:  Hugh K Arnold; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation.

Authors:  Yanhui Xu; Yu Chen; Ping Zhang; Philip D Jeffrey; Yigong Shi
Journal:  Mol Cell       Date:  2008-09-26       Impact factor: 17.970

8.  Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase.

Authors:  Xin Ye; Grzegorz Nalepa; Markus Welcker; Benedikt M Kessler; Eric Spooner; Jun Qin; Stephen J Elledge; Bruce E Clurman; J Wade Harper
Journal:  J Biol Chem       Date:  2004-09-13       Impact factor: 5.157

9.  BUBR1 recruits PP2A via the B56 family of targeting subunits to promote chromosome congression.

Authors:  Peng Xu; Elizabeth A Raetz; Mayumi Kitagawa; David M Virshup; Sang Hyun Lee
Journal:  Biol Open       Date:  2013-03-25       Impact factor: 2.422

10.  Fbw7-dependent cyclin E regulation ensures terminal maturation of bone marrow erythroid cells by restraining oxidative metabolism.

Authors:  Y Xu; K L Swartz; K T Siu; M Bhattacharyya; A C Minella
Journal:  Oncogene       Date:  2013-07-22       Impact factor: 9.867

View more
  4 in total

1.  Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny.

Authors:  María Soledad Rodríguez Varela; Sofía Mucci; Guillermo Agustín Videla Richardson; Olivia Morris Hanon; Verónica Alejandra Furmento; Santiago Gabriel Miriuka; Gustavo Emilio Sevlever; María Elida Scassa; Leonardo Romorini
Journal:  Cell Cycle       Date:  2018-08-10       Impact factor: 4.534

Review 2.  Regulation of Cell Cycle Entry and Exit: A Single Cell Perspective.

Authors:  Hilary A Coller
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 8.915

Review 3.  Emerging Mechanisms of G1/S Cell Cycle Control by Human and Mouse Cytomegaloviruses.

Authors:  Boris Bogdanow; Quang Vinh Phan; Lüder Wiebusch
Journal:  mBio       Date:  2021-12-14       Impact factor: 7.867

Review 4.  FBXW7: a critical tumor suppressor of human cancers.

Authors:  Chien-Hung Yeh; Marcia Bellon; Christophe Nicot
Journal:  Mol Cancer       Date:  2018-08-07       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.